Literature DB >> 24303993

Association between placental pathology and neonatal outcome in preeclampsia: a large cohort study.

Marie-Therese Vinnars1, Josefine Nasiell, Gerd Holmström, Mikael Norman, Magnus Westgren, Nikos Papadogiannakis.   

Abstract

OBJECTIVE: To study associations between placental histopathology and neonatal outcome in preeclampsia (PE). STUDY
DESIGN: The cohort consisted of 544 singleton pregnancies complicated by PE and managed at Karolinska University Hospital, Stockholm, Sweden during 2000-2009. Evaluation of placental histopathology was made by one senior perinatal pathologist, blinded to outcome. Clinical outcome was obtained from prospectively collected medical registry data and medical records. Main outcome measures were intrauterine fetal death, smallness for gestational age, admission to neonatal unit, major neonatal morbidity (defined as presence of intraventricular hemorrhage ≥ grade 3, retinopathy of prematurity ≥ grade 3, necrotizing enterocolitis, cystic periventricular leucomalacia and/or severe bronchopulmonary dysplasia) and neonatal mortality. Logistic regression analyses including gestational age were performed.
RESULTS: Abnormal placental weight, both low (adjusted odds ratio (OR) [95% confidence interval] 5.2 [1.1-24], p = 0.03) and high (adjusted OR 1048 [21-51 663], p < 0.001) for gestational age, was associated with major neonatal morbidity in preterm infants. Accelerated villous maturation was less prevalent in intrauterine fetal death pregnancies (adjusted OR 0.18 [0.04-0.77], p = 0.02). Decidual arteriopathy increased the odds for admission to neonatal care (adjusted OR 2.7 [1.1-6.5], p = 0.03). Infarction involving ≥5% of the placenta was associated with intrauterine fetal death and small for gestational age infants (adjusted OR's 75 [5.5-1011], p = 0.001 and 3.2 [1.7-5.9], p < 0.001; respectively). No relations between histological variables and neonatal mortality could be found.
CONCLUSION: Placental pathology in PE reflects adverse perinatal events and deviant placental weight predicts adverse neonatal outcome in preeclamptic women delivering preterm. Placental investigation without delay can contribute to neonatal risk assessment.

Entities:  

Mesh:

Year:  2013        PMID: 24303993     DOI: 10.3109/10641955.2013.842584

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  6 in total

1.  Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.

Authors:  Karen K Mestan; Nina Gotteiner; Nicolas Porta; William Grobman; Emily J Su; Linda M Ernst
Journal:  J Pediatr       Date:  2017-02-02       Impact factor: 4.406

2.  Pathologic examination of the placenta and its benefits in treatment plan or follow-up of patients: a cross-sectional study.

Authors:  Setareh Akhavan; Sedigheh Borna; Alireza Abdollahi; Mamak Shariat; Narges Zamani
Journal:  Eur J Med Res       Date:  2022-07-11       Impact factor: 4.981

3.  Inflammatory cytokines, placental pathology, and neurological outcomes in infants born to preterm preeclamptic mothers.

Authors:  Alexandra Sotiros; Dianne Thornhill; Miriam D Post; Virginia D Winn; Jennifer Armstrong
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

4.  Genomic Profiling of BDE-47 Effects on Human Placental Cytotrophoblasts.

Authors:  Joshua F Robinson; Mirhan Kapidzic; Emily G Hamilton; Hao Chen; Kenisha W Puckett; Yan Zhou; Katherine Ona; Emily Parry; Yunzhu Wang; June-Soo Park; Joseph F Costello; Susan J Fisher
Journal:  Toxicol Sci       Date:  2019-01-01       Impact factor: 4.109

Review 5.  Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity.

Authors:  Gloria S Pryhuber
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

Review 6.  Adipose tissue function in healthy pregnancy, gestational diabetes mellitus and pre-eclampsia.

Authors:  Cara Trivett; Zoe J Lees; Dilys J Freeman
Journal:  Eur J Clin Nutr       Date:  2021-06-15       Impact factor: 4.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.